FDA approves new Bristol-Myers treatment for multiple myeloma
November 30, 2015 at 11:02 AM EST
Nov 30 (Reuters) - The U.S. Food and Drug Administration said on Monday it had approved a drug to be sold by Bristol-Myers Squibb Co as a treatment for a form of blood cancer.
